Biological rationale for new drugs in the bleeding disorders pipeline.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2011, Issue , 2011, Pages 397-404

  Fogarty, Patrick F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; HEMOSTATIC AGENT; RECOMBINANT PROTEIN;

BIOENGINEERING; BLEEDING; HUMAN; REVIEW; SITE DIRECTED MUTAGENESIS;

BIOENGINEERING; BLOOD COAGULATION FACTORS; HEMORRHAGE; HEMOSTATICS; HUMANS; MUTAGENESIS, SITE-DIRECTED; RECOMBINANT PROTEINS;

EID: 84859377204     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2011.1.397     Document Type: Review

References (0)